Novavax Inc
NASDAQ:NVAX
Novavax Inc
Tax Provision
Novavax Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novavax Inc
NASDAQ:NVAX
|
Tax Provision
-$3.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Tax Provision
-$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Tax Provision
-$617m
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Tax Provision
-$582m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Tax Provision
-$748m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-56%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Tax Provision
-$184.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
See Also
What is Novavax Inc's Tax Provision?
Tax Provision
-3.2m
USD
Based on the financial report for Mar 31, 2024, Novavax Inc's Tax Provision amounts to -3.2m USD.
What is Novavax Inc's Tax Provision growth rate?
Tax Provision CAGR 3Y
-2%
Over the last year, the Tax Provision growth was -13%. The average annual Tax Provision growth rates for Novavax Inc have been -2% over the past three years .